Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-968"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-968"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1842
lpv:speaker	lp:Françoise Castex2
lpv:spokenAs	substitute; EMPL (2009-07-16--2012-01-18)3 member; JURI (2009-07-16--2012-01-18)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 unknown; Parti socialiste (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2009-09-16--2014-06-30)3
lpv:translated text	"I voted against this text, as we cannot allow pharmaceutical companies and the Commission to turn health into a commodity like any other. The link between the pharmaceutical industry in Europe and pharmacovigilance is yet again at the heart of the debate. We cannot let pharmaceutical firms inform the public as they please nor authorise direct advertising to the general public for prescription-only drugs. Indeed, the commercial concerns of these firms are incompatible with the objectives of general interest pursued by our health policies, and it would be dangerous to turn a blind eye."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph